GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
9.62
-1.33 (-12.15%)
Nov 21, 2024, 4:00 PM EST - Market closed
GH Research Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Selling, General & Admin | 13.47 | 11.4 | 10.07 | 6.55 | 0.11 | 0.01 |
Research & Development | 35.06 | 29.82 | 20.48 | 8.55 | 0.34 | 0.3 |
Operating Expenses | 48.53 | 41.22 | 30.68 | 15.1 | 0.45 | 0.31 |
Operating Income | -48.53 | -41.22 | -30.68 | -15.1 | -0.45 | -0.31 |
Interest Expense | -0.73 | -0.72 | -0.12 | -0.01 | - | - |
Interest & Investment Income | 8.98 | 8.98 | 1.17 | - | - | - |
Currency Exchange Gain (Loss) | -2.91 | -2.62 | 7.18 | 5.91 | - | - |
Pretax Income | -41.43 | -35.59 | -22.46 | -9.2 | -0.45 | -0.31 |
Net Income | -41.43 | -35.59 | -22.46 | -9.2 | -0.45 | -0.31 |
Net Income to Common | -41.43 | -35.59 | -22.46 | -9.2 | -0.45 | -0.31 |
Shares Outstanding (Basic) | 52 | 52 | 52 | 44 | 28 | 28 |
Shares Outstanding (Diluted) | 52 | 52 | 52 | 44 | 28 | 28 |
Shares Change (YoY) | 0.38% | 0.00% | 19.09% | 54.03% | 1.28% | - |
EPS (Basic) | -0.79 | -0.68 | -0.43 | -0.21 | -0.02 | -0.01 |
EPS (Diluted) | -0.79 | -0.68 | -0.43 | -0.21 | -0.02 | -0.01 |
Free Cash Flow | - | -33.44 | -26.27 | -15.39 | -0.33 | -0.29 |
Free Cash Flow Per Share | - | -0.64 | -0.50 | -0.35 | -0.01 | -0.01 |
EBITDA | -48.4 | -41.15 | -30.63 | -15.08 | - | - |
D&A For EBITDA | 0.13 | 0.07 | 0.05 | 0.02 | - | - |
EBIT | -48.53 | -41.22 | -30.68 | -15.1 | -0.45 | -0.31 |
Source: S&P Capital IQ. Standard template.
Financial Sources.